Key Updates
Airbus SE has declined 3.69% to $187.10 since the February 13th report, breaking below the critical $190 support level established in early February. The stock now trades 13.81% below its January 12th peak of $217.05 and has extended its YTD decline to -5.70%. The January 30th Bloomberg report confirms that engine supply constraints remain unresolved, with Airbus yet to finalize its 2025 delivery target—a critical cash flow metric for investors. The company's ongoing negotiations with Pratt & Whitney regarding 2026-2027 engine deliveries suggest the previously targeted 900 handovers for 2025 may be reduced, compounding concerns that drove the 2024 target down to approximately 790 units.
Current Trend
Airbus SE is in a confirmed downtrend, declining 5.70% YTD and 10.03% over the past month. The stock has breached the $190 support level that held during the February 2nd decline, establishing a new lower low at $187.10. The 6-month performance of +1.77% masks the recent deterioration, with the stock experiencing accelerating negative momentum across all timeframes: -6.75% in one day, -1.74% over five days, and -10.03% over one month. The breakdown below $190 without any meaningful bounce suggests weakening buyer interest at previous support levels. The stock now trades at its lowest level since the reporting period began, with no established support until the $180-185 zone.
Investment Thesis
The investment thesis for Airbus centers on the company's position as a duopoly player in commercial aerospace with structural long-term demand driven by global air traffic growth and fleet modernization. The thesis assumes Airbus can translate its substantial order backlog into deliveries that generate cash flow, with delivery targets serving as the primary mechanism for value creation. However, this thesis is critically dependent on resolving supply chain bottlenecks, particularly engine availability from Pratt & Whitney. The contaminated metal powder issue affecting geared turbofan engines has forced temporary groundings of A320-family aircraft globally, creating both production delays and potential warranty/support costs. The thesis remains intact if engine supply normalizes and Airbus can achieve delivery targets in the 850-900 range annually, but faces material downside risk if 2025 deliveries fall significantly below 800 units or if engine supply issues extend beyond 2027.
Thesis Status
The investment thesis is under increasing pressure. The January 30th Bloomberg report reveals that Airbus has not finalized its 2025 delivery target less than three weeks before the expected announcement, indicating continued uncertainty around the core cash flow driver. The company's decision to build planes without engines in 2024 and subsequent reduction of the 2024 target to approximately 790 units demonstrates that supply chain issues are materially impacting execution. The ongoing negotiations with Pratt & Whitney for 2026-2027 engine deliveries suggest this is not a near-term problem, potentially extending visibility issues for another 12-24 months. The market's 13.81% decline from peak reflects growing skepticism that management can meet delivery targets, which directly impacts the cash-upon-delivery model central to the thesis. Until Airbus provides clarity on 2025 guidance and secures firm engine delivery commitments through 2027, the thesis remains compromised.
Key Drivers
The primary driver remains engine supply constraints from RTX Corp.'s Pratt & Whitney, with ongoing negotiations for 2026-2027 deliveries creating uncertainty around production ramp-up timelines. The contaminated metal powder issue affecting geared turbofan engines has forced global fleet groundings for component replacement, indicating a systemic quality problem rather than isolated incidents. Airbus's inability to finalize 2025 delivery guidance less than three weeks before announcement suggests management lacks visibility into supply chain resolution, undermining investor confidence in near-term cash flow projections. The 2024 delivery target reduction to approximately 790 units due to faulty A320 fuselage panels reveals multiple concurrent supply chain vulnerabilities beyond engines. The company's strategy of building planes without engines demonstrates production capacity exists but is constrained by external suppliers, creating inventory build-up and working capital pressure until engines arrive and deliveries can be completed.
Technical Analysis
Airbus has broken critical support at $190, which held during the February 2nd decline to $190.04, establishing a lower low at $187.10. The 6.75% single-day decline represents capitulation-style selling pressure, with the stock now trading 13.81% below the January 12th peak of $217.05. The breakdown below $190 on heavy volume suggests this level may now act as resistance on any recovery attempts. The next logical support zone lies at $180-185, representing approximately 17-19% below the January peak. The stock's inability to hold gains from the February 13th bounce (+2.22% to $194.26) indicates weak buying conviction and suggests sellers are using any rallies to exit positions. The 1-month decline of 10.03% versus the 6-month gain of only 1.77% shows recent momentum has completely reversed longer-term trends. Without a catalyst to restore confidence in delivery targets, the technical setup favors further downside testing toward the $180 level.
Bull Case
- Duopoly market structure in commercial aerospace provides pricing power and structural demand as global air traffic continues recovering and growing, with Airbus positioned to capture orders from airlines seeking fuel-efficient aircraft replacements regardless of near-term delivery timing issues (Source)
- Substantial order backlog provides multi-year revenue visibility once supply chain constraints resolve, with payment-upon-delivery model ensuring strong cash conversion when engine availability normalizes and production can accelerate (Source)
- Engine supply constraints are external supplier issues rather than Airbus execution problems, with the company demonstrating production capacity by building planes without engines, positioning for rapid delivery acceleration once Pratt & Whitney resolves contaminated metal powder issues (Source)
- Current valuation at $187.10 reflects 13.81% decline from January peak, potentially pricing in worst-case delivery scenarios and creating entry opportunity if 2025 guidance comes in at 850+ units rather than feared sub-800 levels (Source)
- Ongoing negotiations with Pratt & Whitney for 2026-2027 engine deliveries suggest both parties are working toward resolution, with potential for positive surprise if commitments exceed market expectations and provide clear production ramp timeline (Source)
Bear Case
- Inability to finalize 2025 delivery guidance less than three weeks before expected announcement signals management lacks visibility into core cash flow driver, with potential for significant downward revision from previously targeted 900 units given 2024's reduction to 790 units (Source)
- Engine supply constraints extending into 2026-2027 negotiations indicate multi-year problem rather than near-term bottleneck, with contaminated metal powder issues at Pratt & Whitney forcing global fleet groundings and suggesting systemic quality problems requiring extended resolution timeline (Source)
- Multiple concurrent supply chain vulnerabilities including faulty A320 fuselage panels that contributed to 2024 target reduction demonstrate execution risk beyond engine availability, threatening ability to meet delivery targets even if engine supply improves (Source)
- Building planes without engines creates working capital pressure and inventory build-up without corresponding cash generation, as payment occurs only upon delivery, potentially straining balance sheet if engine delays extend beyond current expectations (Source)
- Technical breakdown below $190 support on heavy single-day volume (-6.75%) suggests institutional selling and loss of confidence, with stock now down 13.81% from January peak and establishing lower lows that could accelerate toward $180-185 support zone without positive catalyst (Source)